J
John G.F. Cleland
Researcher at National Institutes of Health
Publications - 1276
Citations - 125527
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 137, co-authored 1172 publications receiving 110227 citations. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Papers
More filters
Patent
Prognosis of adverse events in patients with suspected chronic heart failure
Joachim Struck,John G.F. Cleland +1 more
TL;DR: In this article, the prognosis of adverse events in patients with stable chronic heart failure by determination of the level of Procalcitonin (PCT) has been investigated in the field of clinical diagnostics.
Journal ArticleDOI
Why does CRT reduce the risk of arrhythmias
TL;DR: This issue of the Journal investigates whether cardiac resynchronization therapy exerts some of its benefits on mortality through a reduction in ventricular tachycardia or ventricular fibrillation, and if so, is this linked to its effects on dyssynchrony.
Journal ArticleDOI
The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure.
Nicola Riccardo Pugliese,Pierpaolo Pellicori,F Filidei,L. Del Punta,Nicolò De Biase,A. Balletti,V Di Fiore,Alessandro Mengozzi,Stefano Taddei,Luna Gargani,Wilfried Mullens,John G.F. Cleland,Stefano Masi +12 more
TL;DR: In this article , the authors investigated the prevalence and clinical value of assessing multi-organ congestion by ultrasound in heart failure (HF) outpatients and explored associations with clinical characteristics and prognosis.
Journal ArticleDOI
Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial.
Job A J Verdonschot,João Pedro Ferreira,Pierpaolo Pellicori,Hans-Peter Brunner-La Rocca,Andrew L. Clark,Franco Cosmi,Joe Cuthbert,Nicolas Girerd,Beatrice Mariottoni,Johannes Petutschnigg,Patrick Rossignol,John G.F. Cleland,Faiez Zannad,Stephane Heymans +13 more
TL;DR: In this article, the authors compared the proteomic profile of patients with and without diabetes among patients at risk for heart failure in the Heart OMics in AGEing (HOMAGE) trial and found that spironolactone had beneficial effect on fibrosis and cardiac remodelling in an at risk population, potentially slowing the progression towards heart failure.
Journal ArticleDOI
Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?
John G.F. Cleland,John G.F. Cleland,Justin Ghosh,Justin Ghosh,Nick Freemantle,Nick Freemantle +5 more
TL;DR: Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?